Our study demonstrated the ability of FGF ligands to stimulate cell proliferation and spheroid growth in ER + breast cancer cell lines without FGFR1 amplification (MCF7, T47D), a phenomenon widely recognized [21, 22]. The gene discussed is FGFR1; the disease is breast cancer.